Swiss Capital – Brokerul Tău pe Piața de Capital
  • News
  • Research
  • About Us
  • Why Should I Invest?
  • English
    • English

ATB RO: Q1 2026 Results | NEUTRAL

by Stoian Cosmin 05/28/2026
05/28/2026
8
Download
File Type: pdf
File Size: 226 Ko
Categories: Antibiotice S.A.
previous post
TEL RO: Q1 2026 Results | POSITIVE
next post
TTS RO: Q1 2026 Earnings preview

Last Articles

  • Trading Taxes and the Unique Tax Return – A Swiss Capital & Think Tax Webinar

    04/03/2026

  • SHARE CAPITAL INCREASE – STAR RESIDENCE INVEST S.A.

    03/05/2026

  • Public Tender Offer for the Shares of INFINITY CAPITAL INVESTMENTS S.A.

    03/04/2026

  • Public Tender Offer for the Shares of LION CAPITAL S.A.

    02/27/2026

  • Public Tender Offer for the Shares of LONGSHIELD INVESTMENT GROUP S.A.

    02/27/2026
Swiss Capital – Brokerul Tău pe Piața de Capital
  • News
  • Research
  • About Us
  • Why Should I Invest?
  • English
    • English
Investments on the capital market involve risks, and before making the decision to invest, it is necessary to consider the financial objectives, the level of experience and the appetite for risk. The analyses, studies, opinions, news, prices or any other information available on the site do not constitute trading recommendations. The content of the website can be changed without prior notice

© 2011-2026 Swiss Capital -All rights reservedDeveloped by HyperSense-Software